KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Net Income (2016 - 2025)

Gilead Sciences (GILD) has disclosed Net Income for 17 consecutive years, with $2.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income rose 41.86% year-over-year to $2.5 billion, compared with a TTM value of $8.9 billion through Dec 2025, up 1748.64%, and an annual FY2025 reading of $8.5 billion, up 1676.62% over the prior year.
  • Net Income was $2.5 billion for Q4 2025 at Gilead Sciences, down from $3.1 billion in the prior quarter.
  • Across five years, Net Income topped out at $3.1 billion in Q3 2025 and bottomed at -$4.2 billion in Q1 2024.
  • Average Net Income over 5 years is $1.3 billion, with a median of $1.6 billion recorded in 2021.
  • The sharpest move saw Net Income surged 8100.0% in 2023, then plummeted 523.88% in 2024.
  • Year by year, Net Income stood at $376.0 million in 2021, then surged by 334.31% to $1.6 billion in 2022, then fell by 13.29% to $1.4 billion in 2023, then grew by 25.85% to $1.8 billion in 2024, then surged by 41.86% to $2.5 billion in 2025.
  • Business Quant data shows Net Income for GILD at $2.5 billion in Q4 2025, $3.1 billion in Q3 2025, and $2.0 billion in Q2 2025.